drugset / Trial / NCT01140672
A Multiple Dose Study To Determine Safety, Tolerability, and Pharmacokinetics Of PF-04634817 In Healthy Adult Subjects
RandomizedParallel-groupDouble-blindBasic science
Summary
The goals of this study are to evaluate the safety and tolerability of multiple ascending doses of PF-04634817 administered orally to healthy adult subjects. In additional, the plasma and urinary pharmacokinetics of multiple ascending doses of PF-04634817 administered orally to healthy adult subjects will be evaluated. Finally, the effect of multiple doses of PF-04634817 on circulating monocytes will be explored.
Timeline
- Start
- 2010-06
- Primary completion
- 2010-10
- Completion
- 2010-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PF-04634817 | Small molecule | 3 mg | Oral |
| Subject | PF-04634817 | Small molecule | 30 mg | Oral |
| Subject | PF-04634817 | Small molecule | 100 mg | Oral |
| Subject | PF-04634817 | Small molecule | 300 mg | Oral |
Indications
No indication recorded.